title: Is liposomal amphotericin B really safety in neonates?
authors.forename: Eda
authors.initials: E
authors.lastname: Karadag-Oncel
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Ozsurekci
authors.forename: Murat
authors.initials: M
authors.lastname: Yurdakok
authors.forename: Ates
authors.initials: A
authors.lastname: Kara
mesh_terms: D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects*; D006801:Humans; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007674:Kidney Diseases / Q000139:chemically induced*; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B